Warning labels on Mounjaro, Ozempic, and a whole host of other similar type 2 diabetes drugs list gastrointestinal problems, such as the following, as potential side effects associated with them: Abdominal discomfort or pain Nausea Bloating Vomiting Constipation Discolored stools Indigestion Diarrhea However, in entering Ozempic, Mounjaro, and other similar medications into the FDA Adverse Events Reporting System (FAERS) Public Dashboard, thousands of reports of much more serious adverse side effects, including the following, come up: Pancreatitis Gallbladder issues Kidney failure Thyroid tumors Cancer Gastroparesis Gastroparesis, also known as stomach paralysis, is what has led to many patients filing lawsuits against the drugs manufacturers most recently
The genetic test reveals genetic predispositionsnot exact protein response or medication outcomes
Furthermore, bis-allylic carbon-containing PUFAs, such as the ones found in cardiolipin, may function as a filter in the inner membrane of the mitochondrial intermembrane space to trap deuterium before it reaches the ATPase pumps, protecting the cells from mitochondrial-respiratory chain dysfunction
A 2017 open-label study found that 300 mg of glutathione daily over four months improved liver enzyme levels and reduced fat accumulation in patients with metabolic-associated fatty liver disease
Therefore, medications cant be used off-label for weight loss in Mississippi
How the studys results will be interpreted or acted upon remains to be seen